Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C10AA07	PMS-ROSUVASTATIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	564,414 L.L
C10AA07	PREVAST 20-IPS	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	639,925 L.L
C10AA08	PIVAL	G	Pitavastatin - 2mg	2mg	Tablet	802,466 L.L
C10AA08	PIVAL	G	Pitavastatin - 4mg	4mg	Tablet	1,265,772 L.L
C10BA03	PRAVAFEN	B	Pravastatin sodium - 40mg, Fenofibrate - 160mg		Capsule, hard	1,264,556 L.L
D02AF	POMMADE ACIDE SALICYLIQUE	G	Salicylic acid - 10%	10%	Ointment	284,127 L.L
D04AB01	PROCOMIL	G	Lidocaine - 10%	10%	Spray	665,202 L.L
D06AX	PENICILLIN DERMIC OINTMENT	G	Penicillin - 5,000IU	5,000IU	Ointment	80,631 L.L
D07AC14	PRENIDERM	G	Methylprednisolone aceponate - 0.1%	0.1%	Cream	312,283 L.L
D07AC18	PEITEL	B	Prednicarbate - 0.25%	0.25%	Cream	507,972 L.L
D07CB01	PANDERM	G	Triamcinolone acetonide - 1mg/g, Gramicidin - 0.25mg/g, Neomycin (sulfate) - 2.5mg/g, Nystatin - 100.000IU/g		Cream	180,075 L.L
D07CB01	POSITON	G	Triamcinolone acetonide - 100mg, Neomycin (sulfate) - 250mg, Nystatin -		Cream	1,064,323 L.L
D11AH01	PROTOPIC	B	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	2,127,303 L.L
G01AA51	POLYGYNAX	B	Nystatin - 100.000IU, Polymixin B sulfate - 35.000IU, Neomycin sulfate - 35.000IU		Capsule, vaginal	407,184 L.L
G02AD02	PROPESS	B	Dinoprostone - 10mg	10mg	Vaginal delivery system	5,838,996 L.L
G02CB03	PROCTIN	G	Cabergoline - 0.5mg	0.5mg	Tablet	350,679 L.L
G02CB03	PROCTIN	G	Cabergoline - 0.5mg	0.5mg	Tablet	1,300,328 L.L
G02CB03	PROCTINMED	G	Cabergoline - 0.5mg	0.5mg	Tablet	473,545 L.L
G02CB03	PROCTINMED	G	Cabergoline - 0.5mg	0.5mg	Tablet	1,689,402 L.L
G03AD01	PURPLE LINE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet, film coated	1,071,570 L.L
G03BB01	PROVIRON	B	Mesterolone - 25mg	25mg	Tablet	391,058 L.L
G03DA03	PROLUTON DEPOT	B	Hydroxyprogesterone caproate - 250mg/ml	250mg/ml	Injectable solution	270,112 L.L
G03DA04	PROGEST	G	Progesterone micronised - 100mg	100mg	Capsule, soft gelatin	368,213 L.L
G03DA04	PROGEST 200	G	Progesterone micronised - 200mg	200mg	Capsule, soft gelatin	411,216 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
G03DA04	PROGESTOGEL	B	Progesterone - 1%	1%	Gel	542,912 L.L
G03DA04	PROLUTEX	B	Progesterone - 25mg	25mg	Injectable solution	5,570,227 L.L
G03DC02	PRIMOLUT NOR	B	Norethisterone acetate - 5mg	5mg	Tablet	296,989 L.L
G03FB01	PROGYLUTON	B	Norgestrel - 0.5mg (tablet 2), Estradiol valerate - 2mg (tablet 1, tablet 2)		Tablet	193,513 L.L
G03GA06	PUREGON	BioHuman	Follitropin beta - 300IU/0.36ml	300IU/0.36ml	Injectable solution	12,929,605 L.L